Introduction
The FDA's 2024 final rule on laboratory-developed tests (LDTs) upended a decades-old enforcement policy — and IVD manufacturers are still adjusting. With tightening 510(k) guidance and rising submission rejection rates, choosing the wrong regulatory consultant doesn't just slow you down. It can sink a product entirely.
IVD regulatory consulting is uniquely specialized. Unlike general medical devices, diagnostics must satisfy overlapping requirements across multiple frameworks:
- FDA 21 CFR Part 820 and Part 809 — device quality and IVD-specific labeling
- ISO 15189 and ISO 17025 — laboratory competence and accreditation
- ISO 13485 — quality management systems
- CLIA standards — clinical laboratory compliance
Generalist medical device consultants often lack the depth to navigate these IVD-specific frameworks effectively.
This post ranks the top 10 IVD regulatory consulting firms serving the US market in 2026. Each firm was evaluated on IVD specialization depth, FDA submission track record, audit clearance rates, and client portfolio diversity — so you can match the right partner to your product and timeline.
TL;DR
- IVD regulatory consulting demands niche expertise in FDA 510(k)/PMA pathways, ISO 13485, ISO 15189, and CLIA compliance
- Firms were ranked on IVD regulatory depth, FDA submission success, audit clearance rates, and engagement flexibility
- Elexes leads with 50+ years of collective experience, 90% audit clearance rate, and dedicated IVD/LDT services
- Prioritize IVD-specific credentials over general medical device experience — the two require very different regulatory skill sets
- Every firm on this list handles FDA-focused IVD work — where they diverge is global reach, pricing transparency, and how they structure engagements
What Is IVD Regulatory Consulting and Why Does It Matter in the US?
IVD regulatory consulting provides specialized advisory services to in vitro diagnostic manufacturers, LDT developers, and diagnostic laboratories. Core services include:
- FDA premarket submissions (510(k), De Novo, PMA)
- Quality management systems under 21 CFR Part 820 and ISO 13485
- Labeling compliance under 21 CFR Part 809
- Post-market surveillance and obligations management
IVD consulting is a distinct specialty from general medical device work. IVDs sit at the intersection of two regulatory layers — manufacturing quality (Part 820) and diagnostic-specific labeling (Part 809) — with LDTs adding a third dimension under CLIA. Few generalist consultants have hands-on experience across all three.
The US market drives the need for this expertise. North America held 47.27% of the global IVD market in 2025, with the global market valued at $106.29 billion. The US LDT segment alone accounts for approximately $20 billion in revenue. With the FDA's 2024 LDT rule vacated by a federal court, regulatory uncertainty isn't going away — companies without experienced IVD consultants risk delayed submissions, failed audits, and costly compliance gaps.
The ten firms below were evaluated on FDA submission track records, IVD-specific regulatory depth, and verifiable client outcomes — so you can match the right partner to your product type and timeline.
Top 10 IVD Regulatory Consulting Firms in the US (2026)
Firms were evaluated across six criteria:
- IVD-specific regulatory expertise
- FDA submission success rates
- Service breadth and lifecycle coverage
- ISO certifications supported
- Client diversity
- Flexible engagement models
Elexes
Elexes is a regulatory consulting firm with 50+ years of collective experience, 250+ successful projects across 200+ product types, and a dedicated focus on IVD, LDT, SaMD, and medical device regulatory approvals. The firm serves 100+ global clients — including IVD manufacturers, LDT developers, and companion diagnostics companies — with a 90% audit clearance rate.
Engagements range from full-time embedded consultants to project-based support, covering end-to-end project management from development through post-market surveillance. Regulatory expertise spans FDA, Health Canada, EMA, and MHRA, with complete client data confidentiality across all engagements.
| Category | Details |
|---|---|
| Key IVD Services | 510(k)/PMA submissions, ISO 13485/15189/17025 QMS support, LDT regulatory strategy, regulatory due diligence, post-market surveillance |
| Regulatory Standards Covered | FDA 21 CFR Part 820/809, ISO 13485, ISO 15189, ISO 17025, ISO 14971, IEC 62304, MDSAP, GCP/GLP |
| Best For | IVD/LDT manufacturers, diagnostic companies, companion diagnostics developers, startups needing end-to-end IVD regulatory support |
Emergo by UL
Emergo by UL is a global medical device and IVD regulatory consulting firm, part of UL Solutions, with deep expertise in US, EU (IVDR), and international IVD market access. The firm operates from 20+ offices on six continents, offering FDA 510(k), Pre-Sub, IDE, and 513(g) submission consulting specifically for IVD companies. Their RAMS digital platform provides automation for regulatory affairs and quality assurance workflows.
| Category | Details |
|---|---|
| Key IVD Services | IVD registration, IVDR compliance, QMS audits, ISO 13485 implementation, US FDA 510(k) support |
| Regulatory Standards Covered | FDA 21 CFR Part 820, EU IVDR, ISO 13485, ISO 15189 |
| Best For | IVD companies seeking simultaneous US and EU IVDR market access |
MCRA
MCRA (Medical & Clinical Research Associates), an IQVIA business, is a US-based consultancy specializing in regulatory strategy, clinical, and reimbursement services for medical devices and IVDs. The firm works with 850+ MedTech companies annually and has navigated hundreds of FDA submissions.
MCRA's integrated regulatory-clinical approach combines CRO services with regulatory consulting for IVD technologies including NGS, companion diagnostics, liquid biopsy, and point-of-care testing.
| Category | Details |
|---|---|
| Key IVD Services | FDA 510(k)/De Novo/PMA strategy, clinical study design, IVD regulatory submissions |
| Regulatory Standards Covered | FDA 21 CFR Part 809/820, ISO 13485 |
| Best For | IVD companies needing combined regulatory and clinical trial strategy |
ProPharma Group
ProPharma Group is a large life sciences consulting firm offering IVD and medical device regulatory support across the full product lifecycle. The firm employs a dedicated diagnostics team with expertise in molecular diagnostics, companion diagnostics, point-of-care testing, immunoassays, and novel assays. ProPharma reported 150+ professionals globally in 2022 and recently expanded with a new office in Hyderabad.
| Category | Details |
|---|---|
| Key IVD Services | FDA submissions, QMS compliance, post-market surveillance, regulatory strategy |
| Regulatory Standards Covered | FDA 21 CFR Part 820/809, ISO 13485, MDSAP |
| Best For | Mid-to-large IVD companies needing full lifecycle regulatory outsourcing |
Regulatory Compliance Associates (RCA)
RCA is an established regulatory consulting firm with a strong US FDA compliance focus, offering IVD-specific services in quality systems, regulatory submissions, and audit readiness. The firm has built a reputation for reliable regulatory outcomes and broad experience across device classes, with specialized support for FDA audit preparation, QMS implementation, and CAPA management.
| Category | Details |
|---|---|
| Key IVD Services | FDA audit preparation, QMS implementation, 510(k) support, CAPA management |
| Regulatory Standards Covered | FDA 21 CFR Part 820, ISO 13485, ISO 14971 |
| Best For | IVD manufacturers seeking FDA audit readiness and QMS remediation |
Rook Quality Systems
Rook Quality Systems is a boutique consultancy with a team of certified quality auditors experienced in IVD and medical device compliance. The firm's differentiators include deep MDSAP expertise, ISO 13485 implementation, and EU IVDR readiness services, positioning them well for IVD companies preparing for multi-market audits or MDSAP certification.
| Category | Details |
|---|---|
| Key IVD Services | QMS audits, MDSAP compliance, ISO 13485 implementation, EU IVDR readiness |
| Regulatory Standards Covered | MDSAP, ISO 13485, EU IVDR, FDA 21 CFR Part 820 |
| Best For | IVD companies seeking MDSAP certification or multi-market audit readiness |
Cannon Quality Group
Cannon Quality Group is a full-service outsourced quality management consultancy serving IVD, SaMD, and medtech companies. The firm's proprietary Audit Efficiency Program and expertise in building QMS frameworks make it a strong fit for IVD compliance, supplier auditing, and FDA 21 CFR Part 820 requirements for startups and scale-ups.
| Category | Details |
|---|---|
| Key IVD Services | QMS build and support, supplier auditing, FDA 21 CFR Part 820 compliance, IVDR readiness |
| Regulatory Standards Covered | FDA 21 CFR Part 820, ISO 13485, EU IVDR |
| Best For | IVD startups and scale-ups needing outsourced QMS building and supplier auditing |
Freyr Solutions
Freyr Solutions is a global regulatory affairs firm with a technology-driven approach to IVD and medical device regulatory submissions. The firm provides regulatory services across 120+ countries, positioning itself as the largest global regulatory solutions provider offering end-to-end support for pharmaceutical, medical device, consumer healthcare, and generic companies.
| Category | Details |
|---|---|
| Key IVD Services | Regulatory submissions, eCTD publishing, regulatory intelligence, IVD registration support |
| Regulatory Standards Covered | FDA 21 CFR Part 809/820, ISO 13485, EU IVDR |
| Best For | IVD companies managing high-volume submissions or multi-country registrations |
Medpoint
Medpoint is a US-based full-service regulatory consulting firm with a team of global consultants offering IVD and medical device quality assurance, regulatory compliance, and supplier auditing services. The firm's breadth of clinical and technical consulting alongside regulatory work makes it a comprehensive option for IVD manufacturers needing integrated QA and clinical support.
| Category | Details |
|---|---|
| Key IVD Services | QA support, FDA 21 CFR compliance, clinical consulting, global supplier auditing |
| Regulatory Standards Covered | FDA 21 CFR Part 820/809, MDSAP, ISO 13485 |
| Best For | IVD manufacturers needing comprehensive QA plus clinical support |
PharmaLex
PharmaLex is a specialized life sciences regulatory and quality management consulting firm serving IVD, pharma, and biotech clients globally. The firm is known for its flexibility in serving companies of all sizes and its strong reputation in IVD post-market regulatory support, regulatory strategy, and IVD lifecycle management.
| Category | Details |
|---|---|
| Key IVD Services | Regulatory strategy, QMS consulting, post-market surveillance, IVD lifecycle management |
| Regulatory Standards Covered | FDA 21 CFR Part 820, ISO 13485, EU IVDR, ISO 14971 |
| Best For | IVD companies needing ongoing post-market regulatory management and lifecycle support |
How We Chose the Best IVD Regulatory Consulting Firms
Selecting an IVD regulatory consulting firm requires prioritizing IVD-specific regulatory depth over general medical device consulting credentials. A common mistake is hiring generalist consultants unfamiliar with FDA 21 CFR Part 809, CLIA waiver pathways, or LDT-specific considerations. That gap causes avoidable submission errors and longer review timelines.
Key evaluation factors included:
- Depth of IVD/LDT regulatory expertise and specialization
- US FDA submission track record (510(k), De Novo, PMA)
- ISO 15189/13485 support and audit clearance rates
- Client diversity across IVD product types
- Flexibility of engagement models (full-time embedded, part-time, project-based)
- Global regulatory reach where relevant
Beyond these core criteria, cost structure and responsiveness also factored into our evaluation. Firms offering project-based or part-time models provide better cost control for startups and small IVD manufacturers than retainer-heavy arrangements requiring long-term commitments.
Conclusion
The IVD regulatory landscape in the US is among the most technically demanding in the diagnostics industry. Choosing a consulting partner with demonstrable IVD-specific expertise (not just broad medical device knowledge) is critical to avoiding submission rejections, audit failures, and market delays.
When evaluating firms, look beyond reputation. IVD-specific credentials, audit clearance history, and the ability to scale support as your product moves from development into post-market stages are what separate a capable partner from a costly one.
For IVD/LDT manufacturers, diagnostic companies, and companion diagnostics developers, Elexes offers:
- 50+ years of collective regulatory expertise across FDA, ISO 13485, and global IVD pathways
- 90% audit clearance rate across 250+ completed projects
- Flexible engagement models — project-based, part-time, or full retainer — matched to your stage and timeline
Reach out for a consultation to discuss your IVD regulatory needs.
Frequently Asked Questions
What's the difference between IVD and IVDR?
IVD (In Vitro Diagnostic) refers to the product category — devices intended for examining specimens from the human body. IVDR (In Vitro Diagnostic Regulation) refers to the EU regulatory framework (EU 2017/746) governing IVD products in European markets. IVDR is distinct from US FDA IVD regulations under 21 CFR Part 809.
What does an IVD regulatory consulting firm do?
IVD regulatory consulting firms guide diagnostic manufacturers through the full regulatory lifecycle. Core services include premarket submissions (510(k), De Novo, PMA), QMS implementation (ISO 13485, 21 CFR Part 820), FDA and notified body audit preparation, post-market surveillance, and global market access strategy.
What FDA pathways are used for IVD approval in the US?
The three primary pathways are 510(k) premarket notification for most Class II IVDs, De Novo for novel low-to-moderate risk IVDs without a predicate, and PMA for high-risk Class III IVDs — per FDA guidance. Class I IVDs are generally exempt from premarket review.
Do IVD manufacturers need ISO 13485 or ISO 15189 certification?
ISO 13485 is the quality management standard for IVD manufacturers — required for CE/IVDR compliance and expected for FDA QMS compliance. ISO 15189 applies to medical laboratories performing diagnostic testing. Manufacturers need ISO 13485; labs running tests need ISO 15189; entities doing both may need both.
What is the difference between an IVD and a laboratory-developed test (LDT)?
An IVD is a commercially manufactured diagnostic device marketed to multiple laboratories or end users and subject to FDA premarket review. An LDT is a test designed, manufactured, and used within a single laboratory. The FDA's 2024 final rule extended premarket oversight to many LDTs, though this rule was later vacated by a federal court.
How long does FDA clearance typically take for an IVD 510(k)?
The FDA's target review time for a standard 510(k) is 90 FDA Days, but actual timelines often extend to 6-12 months depending on submission quality, device complexity, and FDA response cycles.
